Table 9.2.
miRNA | Cell/tissue type | ↑/↓ | Function | Proposed target | Validationa | References |
---|---|---|---|---|---|---|
miR-200a/b/c | HEC-1A, Ishikawa cell lines | ↑ | Proliferation | NAb | Yes | Lee et al. (2011) |
miR-141, miR-429 |
||||||
miR-200c | HEC-1A, Ishikawa cell lines | ↑ | Proliferation | BRD7 | Yes | Park et al. (2012) |
miR-9, miR-27, |
Endometrial carcinoma tissue, Ishikawa cells | ↑ | NDc | FOXO1 (decreased) | ND | Myatt et al. (2010) |
miR-96, miR-153, |
||||||
miR-182, miR-183, |
||||||
miR-186 | HEC-1B cells | Proliferation | FOXO1 | Yes | Myatt et al. (2010) | |
miR-7, miR-149, |
Endometrial carcinoma tissue | ↑ | ND | NA | ND | Myatt and Lam (2007) |
miR-449b, miR-204 |
||||||
miR-204 | HEC-1A cell line | Migration, invasion | FOXC1 | Yes | Myatt and Lam (2007) | |
miR-125b | Type II endometrial carcinoma cells | ↑ | Proliferation, invasion (in vitro and in vivo) | TP53INP1 | Yes | Jiang et al. (2011) |
Target validation was performed by 3″ UTR reporter construct assays and/or, miRNA transfection and Western analysis
NA = function or proposed target was not assessed in the cited study
ND = not determined